Seroprevalence of Anti- N-methyl-D-aspartate receptor antibodies in children with seizures of unknown cause
Background. Anti- N-methyl-D-aspartate receptor (NMDAR) antibodies were found most probably to be accompanied by seizures, particularly in children and sometimes it may be the sole presenting feature. Therefore, testing these antibodies in children with seizure of unexplained cause might be helpful to identify the spectrum of these antibody-mediated disorders. The objective of this study was to determine the frequency of anti-NMDAR antibodies in patients who presented with seizures of unknown cause. Methods. A case-control study was conducted in two hospitals in Medical City Complex-Baghdad in 2019. Children aged 2-18 years who manifested seizures solely without identified causes were recruited over a period of ten months, with an additional sex- and age-matched control group (forty children in each group). Serum was tested in both groups for anti-NMDAR antibodies. Results. In the study group, males predominated in ages younger than 5 years. The mean age was 6.6 years and the mean duration since their seizures’ onset was 2 months. In contrast to male patients, female patients manifested more focal seizures. Only 5 patients (12.5%) were positive for Anti- NMDAR antibodies, in contrast to no one in the control group. Significantly, most of the seropositive patients were females (4, 80%) and showed focal types of seizures (4, 80%). Conclusions. This is a preliminary epidemiological study about the prevalence of anti-NMDAR antibodies in a sample of pediatric patients with isolated seizures of unknown cause. Anti-NMDAR antibodies were found to be prevalent in a relatively small proportion of children who presented with seizures of unknown causes. Demographic characteristics of the patients with variable testing status were found to be nearly comparable to the results from other related studies.
___
1. Panayiotopoulos CP. The new ILAE report on terminology and concepts for the organization of epilepsies: critical review and contribution. Epilepsia 2012; 53: 399-404.2. van Campen JS, Jansen FE, Brouwer OF, Nicolai J, Braun KP. Interobserver agreement of the old and the newly proposed ILAE epilepsy classification in children. Epilepsia 2013; 54: 726-732.
3. Suleiman J, Dale RC. The recognition and treatment of autoimmune epilepsy in children. Dev Med Child Neurol 2015; 57: 431-440.
4. Dubey D, Alqallaf A, Hays R, et al. Neurological autoantibody prevalence in epilepsy of unknown etiology. JAMA Neurol 2017; 74: 397-402.
5. Zekeridou A, Karantoni E, Viaccoz A, et al. Treatment and outcome of children and adolescents with N-methyl-D-aspartate receptor encephalitis. J Neurol 2015; 262: 1859-1866.
6. Suleiman J, Wright S, Gill D, et al. Autoantibodies to neuronal antigens in children with new‐onset seizures classified according to the revised ILAE organization of seizures and epilepsies. Epilepsia 2013; 54: 2091-2100.
7. Suleiman J, Brilot F, Lang B, Vincent A, Dale RC. Autoimmune epilepsy in children: case series and proposed guidelines for identification. Epilepsia 2013; 54: 1036-1045.
8. Gresa-Arribas N, Titulaer MJ, Torrents A, et al. Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study. Lancet Neurol 2014; 13: 167-177.
9. Suh-Lailam BB, Haven TR, Copple SS, Knapp D, Jaskowski TD, Tebo AE. Anti-NMDA-receptor antibody encephalitis: performance evaluation and laboratory experience with the anti-NMDA-receptor IgG assay. Clin Chim Acta 2013; 421: 1-6.
10. Irani SR, Bien CG, Lang B. Autoimmune epilepsies. Curr Opin Neurol 2011; 24: 146-153.
11. Jewett BE, Thapa B. Physiology, NMDA Receptor. PMID: 30137779 Bookshelf ID: NBK519495. In: StatPearls [Internet] Treasure Island (FL): StatPearls Publishing, 2021. Available at: https://pubmed.ncbi. nlm.nih.gov/30137779/ (Accessed on April 2, 2021).
12. Rogawski MA. The NMDA receptor, NMDA antagonists and epilepsy therapy. A status report. Drugs 1992; 44: 279-292.
13. Lau CG, Zukin RS. NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders. Nat Rev Neurosci 2007; 8: 413-426.
14. Seebohm G, Piccini I, Strutz-Seebohm N. Paving the way to understand autoantibody-mediated epilepsy on the molecular level. Front Neurol 2015; 6: 149.
15. Irani SR, Bera K, Waters P, et al. N-methylD-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain 2010; 133(Pt 6): 1655-1667.
16. Brenner T, Sills GJ, Hart Y, et al. Prevalence of neurologic autoantibodies in cohorts of patients with new and established epilepsy. Epilepsia 2013; 54: 1028-1035.
17. Graus F, Titulaer MJ, Balu R, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol 2016; 15: 391-404.
18. Adhikari S, Sathian B, Koirala DP, Rao KS. Profile of children admitted with seizures in a tertiary care hospital of Western Nepal. BMC Pediatr 2013; 13: 43.
19. Mwipopo EE, Akhatar S, Fan P, Zhao D. Profile and clinical characterization of seizures in hospitalized children. Pan Afr Med J 2016; 24: 313.
20. McHugh JC, Delanty N. Epidemiology and classification of epilepsy: gender comparisons. Int Rev Neurobiol 2008; 83: 11-26.
21. Christensen J, Kjeldsen MJ, Andersen H, Friis ML, Sidenius P. Gender differences in epilepsy. Epilepsia 2005; 46: 956-960.
22. Kim DW, Lee SY, Chung SE, Cheong HK, Jung KY, Korean Epilepsy Society. Clinical characteristics of patients with treated epilepsy in Korea: a nationwide epidemiologic study. Epilepsia 2014; 55: 67-75.
23. Remy KE, Custer JW, Cappell J, et al. Pediatric Anti-N-methyl-D-aspartate receptor encephalitis: a review with pooled analysis and critical care emphasis. Front Pediatr 2017; 5: 250.
24. Sai Y, Zhang X, Feng M, Tang J, Liao H, Tan L. Clinical diagnosis and treatment of pediatric anti N methyl D aspartate receptor encephalitis: a single center retrospective study. Exp Ther Med 2018; 16: 1442-1448.
25. Zhang M, Li W, Zhou S, et al. Clinical features, treatment, and outcomes among Chinese children with anti-methyl-D-aspartate receptor (antiNMDAR) encephalitis. Front Neurol 2019; 10: 596
26. Chen CY, Chang YJ, Wu HP. New-onset seizures in pediatric emergency. Pediatr Neonatol 2010; 51: 103- 111.
27. Fiest KM, Sauro KM, Wiebe S, et al. Prevalence and incidence of epilepsy: a systematic review and metaanalysis of international studies. Neurology 2017; 88: 296-303.
28. Berg AT, Shinnar S, Levy SR, Testa FM. Newly diagnosed epilepsy in children: presentation at diagnosis. Epilepsia 1999; 40: 445-452.
29. Camfield P, Camfield C. Incidence, prevalence and aetiology of seizures and epilepsy in children. Epileptic Disord 2015; 17: 117-123.
30. Hauser WA. Epidemiology of epilepsy in children. In: Pellock JM, Nordli DR Jr, Sankar R, Wheless JW, (eds). Pellock’s Pediatric Epilepsy. (4th ed). New York, NY: Demos Medical Publishing, 2017: 177-205.
31. Boggs JG. Women’s Health and Epilepsy. Sex Hormones and Epilepsy. Medscape. Updated December 2018. Available at: https://emedicine. medscape.com/article/1186482-overview#a2. (Accessed on April 2, 2020).
32. Kishk N, Mourad H, Ibrahim S, Shamloul R, AlAzazi A, Shalaby N. Sex differences among epileptic patients: a comparison of epilepsy and its impacts on demographic features, clinical characteristics, and management patterns in a tertiary care hospital in Egypt. Egypt J Neurol Psychiatr Neurosurg 2019; 55: 39.
33. Carlson C, Dugan P, Kirsch HE, Friedman D, The EPGP Investigators. Sex differences in seizure types and symptoms. Epilepsy Behav 2014; 41: 103-108.
34. Viaccoz A, Desestret V, Ducray F, et al. Clinical specificities of adult male patients with NMDA receptor antibodies encephalitis. Neurology2014; 82: 556-563.
35. Vincent A, Irani SR, Lang B. The growing recognition of immunotherapy-responsive seizure disorders with autoantibodies to specific neuronal proteins. Curr Opin Neurol 2010; 23: 144-150.
36. Florance NR, Davis RL, Lam C, et al. Anti-N-methylD-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol 2009; 66: 11- 18.
37. Armangue T, Titulaer MJ, Málaga I, et al; Spanish Anti-N-methyl-D-Aspartate Receptor (NMDAR) Encephalitis Work Group. Pediatric anti-N-methylD-aspartate receptor encephalitis-clinical analysis and novel findings in a series of 20 patients. J Pediatr 2013; 162: 850-856.e2.
38. Cabezudo-García P, Mena-Vázquez N, VillagránGarcía M, Serrano-Castro PJ. Efficacy of antiepileptic drugs in autoimmune epilepsy: a systematic review. Seizure 2018; 59: 72-76.
39. Palace J, Lange B. Epilepsy: an autoimmune disease? J Neurol Neurosurg Psychiatry 2000; 69: 711-714.
- ISSN: 0041-4301
- Yayın Aralığı: Yılda 6 Sayı
- Başlangıç: 1958
- Yayıncı: Hacettepe Üniversitesi Çocuk Sağlığı Enstitüsü Müdürlüğü
Sayıdaki Diğer Makaleler
Neonatal diabetes mellitus due to a new KCNJ11 mutation - 10 years of the patient’s follow-up
Maja D JESIC, Helena STOCK, Smiljka KOVACEVIC, Marko SAVIC, Milo M JE İ, Vera ZDRAVKOVIC
Ümmüşen KAYA AKÇA, Okan SÖKMEN, Ertuğrul Çağrı BÖLEK, Selcan DEMİR, Levent KILIÇ, Işın ÜNAL, Yelda BİLGİNER
Beril DİLBER, Gökçe PINAR REİS
Oral health status in children with familial Mediterranean fever
Pelin ESMERAY, Tülin İleri KEÇELİ, Meryem TEKÇİÇEK, Ezgi Deniz BATU, Yelda BİLGİNER, Seza ÖZEN, Zehra Serap ARICI, Hande KONŞUK ÜNLÜ
Mohammed Abdulrasol ABDULAMER, Nebal Waill SAADİ, Batool Ali Ghalib YASSİN, Imad AL-JUMAİLİ
Young Mi HAN, Mi Hye BAE, Kyung Hee PARK, Shin Yun BYUN, Miran LEE, Narae LEE, Choongrak KİM
Yun-peng Lİ, Hong-cheng SONG, Xiao-li MA, Le-jian HE, Wei-ping ZHANG
Anaphylaxis to levetiracetam in an adolescent: a very rare occurence
Şeyma KAHRAMAN, Şeyda DEĞERMENCİ, Mehmet Ali OKTAY, Deniz MENDERES, Okşan Derinöz GÜLERYÜZ, Ebru ARHAN, Arzu BAKIRTAŞ, Hacer İlbilge ERTOY KARAGÖL
Sevim Kuyumcu KAVUNCU, Pınar NALÇACIOĞLU, Gölge ACAROĞLU
İbrahim KARNAK, Ahmet Cevdet CEYLAN, Mithat HALİLOĞLU, Alev ÖZÖN, Diclehan ORHAN, Tezer KUTLUK